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ABSTRACT 
Tumour cell lines are widely used for cancer research, but challenges regarding quality 
control of cell line identity, cross-contamination and tumour somatic molecular stability 
remain, demanding novel approaches beyond conventional short tandem repeat profiling.  
We analyzed 21 commonly used multiple myeloma (MM) cell lines obtained from public 
repositories by digital multiplex ligation-dependent probe amplification (digitalMLPA) to 
characterise germline single nucleotide (SNP), insertion/deletion polymorphisms (indels) and 
somatic copy number aberrations (CNA). Using generated profiles and an in-house 
developed analytical pipeline we performed blinded experiments to determine capability of 
digitalMLPA to predict cell line identity and potential spike-in DNA contamination in 41 
anonymised cell line samples. The dominant cell line was correctly identified in all cases, 
and cross-contamination was correctly detected in 33 out of 37 samples with spike-in DNA; 
there were no false-positive predictions. The four samples in which spike-in was not 
detected all carried very low levels of contamination (1%), whereas levels of contamination 
≥5% were correctly identified in all cases. Unsupervised clustering of CNA profiles identified 
shared commonalities which correlated with initiating immunoglobulin heavy locus (IGH) 
translocation events. Longitudinal CNA assesment of nine cell lines revealed changes under 
standard culturing conditions not detected by indel profiling alone. Our results suggest that 
digitalMLPA can be utilized as a high-throughput tool for advanced quality assurance for in 
vitro cancer research.  
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INTRODUCTION 
Human cancer cell lines are indispensable tools for a wide range of research applications 
from basic biology to pre-clinical drug profiling, the outcomes of which frequently feed into 
decision making processes of research and development programs that can ultimately 
impact patient care. Recently, the degree of inter- and intra-laboratory variation in key 
molecular features of widely used cell lines, often established decades ago, has been 
described, including occurrence of contamination, highlighting the urgent need for improved 
and applicable quality control tools for cell line identification and molecular characterisation.1-
3
 Short tandem repeat (STR) profiling is widely used for cell line identification, but has 
inherent limitations in terms of number of markers assessed and varying sensitivity regarding 
detection of minor contaminants. Furthermore, STR typing does not provide information 
about key somatic molecular tumour features. We describe here a novel approach, using 
digital multiplex ligation-dependent probe amplification (digitalMLPA) for combined 
assessment of insertion/deletion and single nucleotide polymorphisms (SNP) for cell line 
identification and tumour-specific copy number aberration profiling for molecular 
characterisation of cell lines, using human multiple myeloma (MM) cell lines as a 
representative example. We demonstrate high sensitivity for detection of cross-
contamination in blinded experiments, identification of cell line specific CNAs and their 
longitudinal changes in long-term cultures, highlighting digitalMLPA’s potential for application 
in high throughput cell line quality control and management, in particular for laboratories 
working with different cell lines.  
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MATERIALS AND METHODS 
Multiple myeloma (MM) cell line DNA source 
MM cell line DNA samples used in this study were purchased directly from Leibnitz Institute 
German collection of microorganisms and Cell Cultures (DSMZ) for 18 cell lines (AMO-1, 
ARH-77, COLO-677, EJM, IM-9, JJN-3, KMS-12-BM, KMS-12-PE, L-363, LOPRA-1, LP-1, 
MOLP-2, MOLP-8, NCI-H929, OPM-2, RPMI-8226, SK-MM-2 and U-266) by MRC Holland, 
Amsterdam. DNA for nine cell lines, some nominally identical with MRC obtained cell lines, 
were provided by the Myeloma Molecular Therapy Team at the Institute of Cancer Research 
(ICR), London, UK. These had been obtained as viable cells from the DSMZ (JJN-3, KMS-
12-BM, L-363, LP-1, NCI-H929, RPMI-8226), JCRB (KMS-11), ECACC/ATCC (JIM-3, 
MM1.S, MM1.R) repositories, expanded and DNA extracted from early (<10) passages. 
Preparation of cell lines for contamination detection study 
Two single-blinded batches of samples for the cell line contamination study were prepared, 
one by MRC Holland and one by ICR, containing either DNA from a single cell line or spike-
in cell line DNA from two different cell lines with varying proportions (1-50%) of spike-in 
DNA. 
The external blinded samples 1-12 were prepared at ICR and sent to MRC Holland labelled 
with unique pseudonymised identifiers (numbers 1-12) only. Analysis was performed by 
MRC Holland blinded to the cell line information and cell line identity and spike-in estimates 
were transferred to ICR using anonymised labels, which were then matched with original cell 
line/spike-in. 
Blinded samples 13-45 were prepared at MRC Holland by a laboratory scientist, labelled 
with unique pseudonymised identifiers, which were used for digitalMLPA analysis. Data was 
analysed separately by a bioinformatician using pseudonymised identifiers and results 
passed back to the laboratory scientist for de-pseudonimsation and matching of results.  
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Cell line derived DNA analysis by digitalMLPA 
DigitalMLPA is a next-generation sequencing-based multiplex ligation-dependent probe 
amplification variant which allows analysis of up to 1000 MLPA probes in a single reaction 
and the amplicon quantification by Illumina sequencers. DigitalMLPA was performed as 
described previously.4 Briefly, DNA sample mixed with sample identification barcode was 
denatured, followed by overnight hybridisation of digitalMLPA probes, and ligation of 
hybridised probes. Ligated probes were further PCR amplified, and the PCR products of all 
samples were combined and loaded to MiSeq or MiniSeq Illumina sequencer. 
In the current study digitalMLPA was used to perform profiling of 254 SNPs, in MM cell line 
derived DNA samples by using a dedicated digitalMLPA probemix which contains 45 probes 
for input DNA and assay quality control alongside 254 SNP-specific probes and to detect 
common copy number alterations in MM cell lines with total of 282 target copy number 
probes included in the newly developed research version of D006-X2 Multiple Myeloma 
digitalMLPA probemix (MRC Holland bv, Amsterdam). This D006-X2 probemix also contains 
one probe specific for BRAF V600E mutation, 96 reference, 45 input DNA and assay quality 
control, six X and Y chromosome-specific and 39 pairs of SNP probes for sample 
identification and detection of sample contamination. At least triplicates of 40 ng of human 
genomic DNA (G1471, Promega, Mannheim, Germany) were used as a normal diploid copy 
number reference sample DNA in all digitalMLPA experiments. 
For each reaction, in total 20-100 ng DNA sample was used. Concentration of cell line DNA 
was measured by Nanodrop (Nanodrop-8000; Thermo Fisher Scientific, Waltham, MA, 
USA), and subsequent dilution was made with TE buffer (T10E1 buffer: 10 mmol/L Tris-HCl 
pH 8.5 and 0.1 mmol/L EDTA) whenever possible to obtain DNA samples with 10 ng/μl 
concentration.  
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DigitalMLPA SNP profiling for cell line identification 
Cell line identification by digitalMLPA SNP profiling uses the intra-normalized read-ratio on a 
set of 254 SNP probes. The read-ratios of an unknown cell line are compared against those 
of known cell-lines. In case of an impure unknown cell line, the main cell line will be identified 
in this manner. The contaminating cell-line and the degree of contamination may be 
identified based on the non-zero ratios in the unknown sample for SNP probes that are 
absent in the main cell line, as described in detail below. 
Preparation of various human cell lines for contamination detection study 
Single-blinded samples of various human cancer cell lines obtained from DSMZ for the cell 
line contamination study were prepared  by MRC Holland containing either DNA from a 
single cell line or spike-in cell line DNA from two different cell lines with varying proportions 
(1-10%) of spike-in DNA. Blinded samples were prepared at MRC Holland by a laboratory 
scientist, labelled with unique pseudonymised identifiers, which were used for digitalMLPA 
analysis. Data was analysed separately by a bioinformatician using pseudonymised 
identifiers and results passed back to the laboratory scientist for de-pseudonimsation and 
matching of results.  
DigitalMLPA SNP profiling for cell line identification 
SNP profiling of cell lines was performed in multiple steps. In the first analysis step FASTQ 
conversion was performed, where each read of MiSeq FASTQ output file was assigned to a 
particular reaction (using the barcode sequence) and to a particular digitalMLPA probe. After 
FASTQ conversion, intra-sample normalisation was done to normalise the read count for 
each SNP-specific probe in two steps: 1) for each sample the Median Total Reference probe 
read count (MTR) was calculated, 2) the read count of each probe is divided by the MTR: 
 =

	
 () 
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Where Csp is the read count of probe p in sample s, Csr is the read count of reference probe r 
in sample s, and Rsp is the (within sample) ratio of probe p in sample s. 
For an unidentified sample Rsp ratios of the 254 SNP probes were compared to the ratios in 
known cell lines. For each known cell line the sum of squares of the differences between the 
ratios were calculated:  
 =  − 


 
Where Rcp is the ratio of known cell line c on SNP probe p and Rup the ratio of the 
unidentified sample u on the same SNP probe p. The known cell line c with lowest (near 0) 
sum of squares SSc was our best identification for sample u. 
The same method was also used to identify the predominant cell line from a mix-up of two 
multiple myeloma cell line DNA samples. In that case SSc will be further from 0 depending 
on the degree of impurity. Once the predominant cell line was identified, sample impurity 
became apparent when investigating the SNP probes that have a Rsp ratio of 0 in the pure 
cell line of the main ingredient. We called such SNP probes “informative probes”. Any non-
negligible ratios (Rsp >= 0,005) ratios in the unknown sample u on such informative probes 
were indicators of a cell line impurity.  
By investigating the informative probes we could identify which cell line is causing the 
impurity, given that we had information on that cell line SNP profile. For each cell line an 
“informative SNP measure” was calculated as follows:  
 =  	 > 0; 	( > 0; 1; −1); 	( = 0; 1; 0)
$

 
Where Rui is the ratio of the contaminated sample u on informative probe i and Rci is the ratio 
of the potential contaminant cell line c on the same informative probe i, and using the 
structure if(logical test;[value if true];[value if false]). 
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In words: sum was calculated over all n informative probes. A non-negligible ratio Rui on 
informative SNP probe i in mix-up sample u was considered to be likely caused by presence 
of contaminant. Therefore, if a non-zero ratio Rci was found in potential contaminant c, mc 
measure was raised by 1. However, if ratio Rci was 0, penalty of -1 was added to mc, as this 
cell line failed to explain the non-zero ratio Rui. When an Rui of 0 coincided with a zero ratio 
Rci, mc was raised by 1. When an Rui of 0 miss-matched with a non-zero ratio Rci, 0 was 
added instead of a penalty as low contaminant concentrations might have led to some 
contaminant signals falling below our noise cut-off (0.5% of MTR but at least 10 reads). 
Finally, cell line c with the highest mc was considered as the most likely candidate for the 
contaminant. 
Once the most likely predominant and the contaminating cell line were identified, a 
percentage of contamination was be estimated as follows:  
% =
∑ 
$
  
Where Rui is the ratio of the contaminated sample u on informative probe i and Rci is the ratio 
of the contaminant cell line c on the same informative probe i, and i is each of the n probes 
that have a Rsp ratio of 0 in the pure cell line of the main ingredient, but not in the 
contaminant.  
Likewise, the percentage of the main ingredient was estimated by: 
% =
∑ 
$
  
Where Rmi is the ratio of the main ingredient m on informative probe i, and i is each of the n 
probes that have a Rsp ratio of 0 in the pure cell line of the contaminant but not in the main 
ingredient. Ideally, Pm should approach (1-Pc). Above described estimation of percentage 
depends strongly on the number of informative probes, and can vary greatly depending on 
the cell lines content. 
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SNP dendrogram heatmap 
Read counts of all SNPs per cell line were converted to a distances with the maximum 
number of 141 unique SNP values. A heatmap was generated using R version 3.6.1 (2019-
07-05, https://www.R-project.org/, last accessed 2020-04-16), Rstudio version Version 
1.2.5001 (last accessed  2019-07-05, http://www.rstudio.com/, last accessed 2020-04-16). A 
142 step color gradient was created with 0 set to 'white' and the maximum value of 141 set 
to "black" using the R package RColorBrewer (2019-07-05, https://CRAN.R-
project.org/package=RColorBrewer, last accessed 2010-04-16) and subsequently plotted 
using the R package pheatmap (2019-07-05, https://CRAN.R-
project.org/package=pheatmap, last accessed 2020-04-16) using supervised clustering. 
 
digitalMLPA for copy number aberration (CNA) analysis 
For copy number characterisation, digitalMLPA experiments using D006-X2 probemix were 
analysed by an in house software by MRC Holland as previously described.4 The FASTQ is 
converted to readcounts, and subsequently to ratios. The final analysed data shows the read 
ratio - relative number of reads for each probe in each reaction, as compared to reference 
reactions - commercially obtained blood-derived genomic DNA of male donors (Human 
Genomic DNA: G1471; Promega), where ratio of 1.0 corresponds to two copies of probe’s 
target DNA (n = 2), a read ratio of 0.5 corresponds to a single copy, and a read ratio of 1.5 
corresponds to three copies in a homogeneous sample with 100% tumour cell percentage 
consisting of only one major clone. 
Cell line clustering based on digitalMLPA CNA profiles 
To investigate the molecular subgroups represented by the cell lines tested, we clustered the 
CNA profiles using R version 3.6.1 (2019-07-05, https://www.R-project.org/, last accessed 
2020-04-16), Rstudio version Version 1.2.5001 (2019-07-05, http://www.rstudio.com/, last 
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accessed 2020-04-16) and the ComplexHeatmap package (Bioconductor release 3.10, 
2019-10-30, https://bioconductor.org/packages/ComplexHeatmap/, last accessed 2020-04-
16) using k-means clustering.5 Firstly, the optimal number of clusters was calculated using 
an elbow plot, and then clustering was performed using the standard k-means algorithm. 
Longitudinal cell cultures and CNA profiling 
In total nine MM cell lines (JIM-3, JJN-3, KMS-11, KMS-12-BM, L-363, MM1-R, MM1-S, NCI-
H929 and RPMI-8226) were cultured in culture medium with FBS and, if indicated, 
supplements, as recommended by the respective cell line repository that provided viable 
cells (see above). All cells were grown in humidified incubators in 5% CO2 at 37°C, 
passaged in recommended intervals and kept at recommended densities, respectively. Cells 
were harvested after 10, 20, 30, 40 and 50 passages in RLTplus buffer (QIAGEN, Hilden, 
Germany). DNA was extracted using the AllPrep kit (QIAGEN), and was sent to MRC 
Holland for copy number and SNP profiling by digitalMLPA analysis. 
RESULTS 
Cell line identity and contamination profiling using high throughput digitalMLPA of 
germline CNV 
We applied digitalMLPA, a high-throughput method for SNP and focused CNA assessment, 
to profile a range of widely used human MM cell lines, the majority directly sourced from 
public repositories. Genetic ‘fingerprint’ profiles for each of the MM cell lines were generated 
from SNP data and subsequently used to determine digitalMLPA capability for blinded cell 
line identification and detection of spike-in ‘contamination’ based on algorithms specifically 
designed and developed for this purpose by the bioinformatics team at MRC Holland (see 
Materials and Methods). 
To test capabilities of digitalMLPA in conjunction with developed algorithms for detecting cell 
lines and their potential contamination, 41 samples were analysed in a blinded fashion, of 
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which 12 samples were prepared by scientists at the ICR myeloma laboratory and 29 by 
scientists at MRC Holland. Data analysis was performed centrally by the MRC Holland 
bioinformatics team who were blinded to cell identity and to whether samples contained a 
unique cell line source or a potential spike in from another cell line. In total, 4/41 samples 
contained a single cell line DNA source only and no spike-in contamination. Of the 37 
samples that had DNA from second cell line spiked in, 21/37 had a spike in of ≥5% and 
16/37 a spike in of <5%, the latter specifically to test the potential limits of detection. 
Individual cell line and spike in sample digitalMLPA SNP read counts are shown in 
Supplemental Table S1. Results in Table 1 demonstrate that the dominant cell line was 
correctly identified using the fingerprint profiles of all 41 (100%) of samples. Across all 
experiments, detection of any contamination by spike-in with a second cell line was achieved 
for 34/37 cell lines. The three samples for which spike-in contamination was not detected 
contained very low (1%) spike-in DNA.  There were no false positive predictions of 
contamination for the samples without spike-in. For 29 of the 34 samples with spike-in, the 
identity of the spiked-in cell line was correctly predicted based on SNP profiles and an 
estimate of the level of contamination similar to the spiked-in amount was predicted for most. 
The five samples for which contamination was detected but the spiked-in cell line could not 
be identified had low spike-ins of <5%. These results led us to consider 5% as a potential 
high confidence cut-off for contamination detection. When excluding the samples with <5% 
spike-in DNA, contamination in the remaining 21 samples was detected and identity of the 
contaminating cell line identified correctly for all (100%) by digitalMLPA (Table 1). 
For the samples with <5% spiked-in DNA, contamination was correctly detected in 12/16 
samples and not detected (false negative) in the remaining four. Based on this heterogeneity 
in detection, we performed SNP heterogeneity analysis of cell lines. We identified several 
distinct clusters, and cases for which contamination was difficult to detect tended to be within 
similar clusters. Different clusters were enriched for similar ethnic background of the patients 
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from whom the respective cell lines were originally derived, as determined from publicly 
available information (Figure 1).  
Furthermore, for human cancer cell lines other than MM detection of any contamination by 
spike-in with a second cell line or the absence of it was achieved for 16/16 samples 
(Supplemental Table S2).   
High-throughput molecular characterisation of cell lines 
We used the 282 CNA detection probes, curated to include frequent areas of somatic CNAs 
in MM, to molecularly characterise cell lines. Normalized digitalMLPA copy number counts 
per probe are provided in Supplemental Table S3. For subsequent analysis, we excluded 
EBV positive cell lines and those of uncertain origin (AMO-1, ARH-77, COLO-677 and IM-9), 
although including these cell lines did not fundamentally change the results (Supplemental 
Figure S1). Interestingly, results including the above mentioned cell lines demonstrate the 
similarity in molecular profiles of RPMI-8226 and COLO-677, the latter identified as a 
contaminant cell line of RPMI-8226 in 2010.6 Molecular profiles of EBV-positive cell lines IM-
9 and ARH-77 showed CNA patterns atypical for MM with absence of and/or unusual 
chromosomal location of CNAs (including del1q and del3q), respectively.  
We next clustered confirmed MM cell lines based on their CNA profiles. Most cell lines 
clustered in one of three clusters, with EJM showing a distinct, fourth CNA profile cluster 
(Figure 2). Clusters differed in specific regional characteristics: cell lines in cluster3 
consistently showed amplification of 1q and del(13), cluster2 was characterised by presence 
of copy number gain of the MYC locus, gain(11) and del(17p), whereas cluster1 cell lines 
mostly carried gain(1q) and cell lines in this cluster seemed to carry overall fewer CNAs 
(MM.1S/R, MOLP-8 and L-363) (Figure 2). Clusters were associated with pathogenic IGH 
translocation subtypes: all cell lines in cluster3 (with the exception of LOPRA-1, for which no 
information is available in the public domain) carried t(4;14), cell lines in cluster2 had 
t(11;14) and those in cluster1 contained predominantly MAF or MAFB translocated cell lines.  
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Regional deletions of chr(1p) were present across all clusters and CDKN2C homozygous 
deletion was detected in 8/18 (44%) cell lines (no detectable copies), whereas complete loss 
of tested exons of FAM46C were identified in only two cell lines. As described before, TP53 
deletions were detected in the majority of cell lines, including three with complete loss of 
TP53 exons. EJM showed distinct and marked gain of MAP3K14 on chromosome 17q21, up 
to 12-fold from baseline copy number, encoding for the NF-κB signalling inducing kinase 
NIK. The digitalMLPA probemix contains a mutation detection probe for the canonical BRAF 
V600E mutation. None of the tested cell lines carried this mutation, in line with previously 
published data.7 
Longitudinal profiling reveals regional genomic drift of CNA in long-term myeloma 
cell line cultures, whereas SNP profiles remain stable 
In addition to germline sample identity, genetic heterogeneity in somatic tumour aberrations 
has been recently described, with potential impact on reproducibility of research findings. 
Nine commonly used MM cell lines (JIM-3, JJN3, KMS-11, KMS12-BM, L-363, MM1.R, 
MM1.S, NCI-H929 and RPMI-8226), obtained from public repositories in early passages 
were kept in long-term culture under recommended culturing conditions for up to 50 
passages and DNA was harvested during passage after every 10 passages. The 
digitalMLPA probemix interrogates key candidate loci of CNA in MM but also provides a 
virtual karyogram across all chromosome arms. Overall, the virtual karyogram remained 
relatively stable throughout the 50 passages across the cell lines (Figure 3). However, there 
were regional changes in copy number, some of which occurred relatively early. Early 
changes were noted in MM1.R, where a region of chr17 gained extra copies from 10 
passages onward (Supplemental Figure S2), but also RPMI-8226, with copy number gain 
of chr7 at baseline changing towards a neutral pattern after 10 passages (Supplemental 
Figure S2). Of note, NCI-H929 acquired additional copies of IRF4 a key myeloma oncogene 
on chr6p over baseline from passage 30 onwards (Figure 4). Also, RPMI-8226 lost 
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additional copies of BIRC2/BIRC3 and ATM on chr11, present at baseline, beyond passage 
30 (Figure 4).  
Analysis of the 39 pairs of fingerprint SNP probes showed a generally stable SNP pattern for 
all MM cell lines throughout 50 cell passages, suggesting that SNP identification alone does 
not capture somatic genetic drift to the same extent as CNA probes in cell lines (Figure 3).  
 
DISCUSSION 
Correct tumour cell line identification, detection of potential cross cell-line contamination and 
monitoring of stability of tumour somatic mutations is of hallmark importance for consistent 
and reproducible in vitro cancer research. Beyond the technical limitations of STR typing, 
most currently available genome-wide profiling tools require significant financial or 
computational resource, currently limiting their applicability for longitudinal, high-throughput 
quality control.8 DigitalMLPA is an analysis tool that requires low DNA input (< 20 ng) and 
limited hands-on time for widely scalable library preparation for common next-generation 
sequencers (Illumina platforms). Results can be generated on standard desktop computers 
without specific bioinformatics skills. 
Our results suggest that digitalMLPA is suitable for high-throughput quality control of cell line 
identity, cross cell-line contamination and molecular stability, using MM as an example. We 
found consistent identification of blinded cell line samples and detection of spike-in cross-
contamination, including identification of the contaminating cell line, by digitalMLPA SNP 
profiling. Our results suggest ≥5% threshold for high confidence identification of contaminant 
DNA for standard use, but lower thresholds may technically be achievable for special 
applications. Importantly, the experiments were not designed to perform research forensic 
identification of trace contaminants, but to identify the threshold with which contamination 
can be reliably picked up in a high-throughput profiling set-up. In addition, our results show 
that cell lines derived from patients with similar ethnic background may be particularly 
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challenging to discriminate at very low spike-in levels <5%. This information can help in 
designing experiments where cross-contamination may be a particular risk. In addition, the 
digitalMLPA probe mix is hypothetically technically open for future adjustment to include 
SNPs for sensitive detection of inter-species contamination, potentially relevant for xenograft 
experiments or for detection of micro-organisms such as mycoplasma. 
We demonstrate by somatic CNA profiling that the MM architecture of structural cell line 
aberrations remains associated with the primary pathogenetic IGH translocations. This is 
remarkable, since all cell lines have been derived from late-stage MM/plasma cell leukaemia 
and have been kept in vitro for decades. Our data suggests that high copy number gain of 
chr(1q) is particularly enriched in the t(4;14) cell lines, whereas 1q gain in t(14;16) and 
t(14;20) is present, but less pronounced. More recently, copy number aberrations of MCL1 
on chr1q have attracted attention, both as a potential resistance factor for BCL2 inhibition 
and as a putative target mutation for MCL-1 inhibitors.9, 10 DigitalMLPA allows for rapid 
assessment copy number status with probes specifically interrogating MCL1 for in vitro as 
well as primary patient cell analysis. The identified amplification of MAP3K14 in the EJM cell 
line, encoding for the NF-κB signalling inducing kinase NIK, confirms previous reports, but it 
is notable that the overall chromosomal aberration pattern of EJM seems to be different from 
the majority of profiled cell lines.11 A shared feature across many cell lines across clusters 
seems to be complete loss of the CDKN2C locus. Although homozygous CDKN2C deletions 
are present in patient samples at diagnosis, they occur at relatively low frequency, and may 
indicate a particular advantage of CDKN2C loss for in vitro growth of myeloma cells.12  
Our results also demonstrate that multiple regional CNA changes in longitudinal cell culture 
experiments evolve, even under recommended culture conditions without obvious external 
selective pressures. Some of the changes were already detectable after 10 passages. The 
functional impact of these changes is currently unknown, but CNA changes included specific 
MM oncogenes such as IRF4 on chr6 and BIRC2/3 on chr11.12-14 DigitalMLPA opens the 
opportunity to investigate such changes, especially in longitudinal experiments and where 
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selective pressures are exerted on cell lines. Little has been reported in this respect to date.  
A potential application could also be genetic modification experiments using CRISPR/Cas9 
or similar, which may favour selection of chromosomally variant sub-clones that would not be 
detected without quality control assessment.15 DigitalMLPA as basic rapid screen in such 
settings can be complemented by more complex methods, where indicated and accessible.  
In summary, we demonstrate here that digitalMLPA as a targeted approach for SNP and 
somatic CNA profiling provides highly informative results for molecular cell line identification 
and quality control. The lower complexity of results compared to whole genome or exome 
sequencing or even SNP microarrays are balanced by digitalMLPA’s lower cost, high 
throughput applicability and low requirements in terms of bioinformatics skills or 
infrastructure, making it an accessible tool for rapid and high-throughput molecular quality 
assurance for in vitro cell line research.  
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FIGURE LEGENDS 
Figure 1. SNP dendrogram generated by unsupervised clustering of indel and single 
nucleotide variation cell line fingerprints. Ethnicity column indicates ethnic descent of 
patient that respective cell lines were derived from: a=African, u=Unknown, ea=East Asian, 
e=European. 
Figure 2. Clustering of cell lines based on CNA profiling. The dendrogram on the left 
shows four clusters generated using k-means based on copy number ratios, where ratio 1 
corresponds to baseline, lower ratios indicating a relative loss and higher numbers a relative 
gain. Below chromosomes are indicated by black and white blocks corresponding to odd and 
even chromosomes respectively. The X chromosome appears as grey. Canonical 
translocations are depicted by the colored row annotations on the right of the heatmap.  
Figure 3. Longitudinal stability of somatic CNA and indel/SNP fingerprint profiles from 
long-term cultures of nine myeloma cell lines. Cell lines obtained from the repository 
were cultured under optimal recommended conditions for 50 passages and digitalMLPA was 
performed after each 10 passages. Blue indicated genetic loss and red genetic gain of 
CNAs. Indels are coded light grey, dark grey or black for values of 0, 1 or 2 alleles of the 
relevant indel. White indicates borderline count that does not allow unique allocation to a 
discreet allelic status. 
Figure 4. Detail of focal CNA drift of multiple myeloma cell lines with increasing 
passages. Copy number ratio profiles of digitalMLPA probes including identifiers of genes 
assayed directly by digitalMLPA; A. on chr6 in NCI-H929 cell line, and B. on chr11 in RPMI-
8226 cell line.  
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TABLES 
Table 1. Cell line contamination detection by digitalMLPA SNP profiling in single-
blinded cell line DNA samples with and without spike-in from another cell line.  
Bl
in
di
n
g Blinded 
mix-up 
sample 
ID 
Cell line  
Cell line 
identified by 
digitalMLPA  
(+ yes, – no) 
Spike-in/ 
contaminating  
cell line 
Spike-in/contamination 
predicted by digitalMLPA 
(+ yes, – no) 
% of 
contaminating  
cell line  
% of contaminating 
cell line as 
calculated by 
digitalMLPA 
Ex
te
rn
al
 
(IC
R)
 
1  KMS-11 + L-363 + 5 12 
2 RPMI-8226 + NCI-H929 + 4 3 
3 JJN-3 + LP-1 + 50 41 
4 KMS12BM + - - 0 0 
5 JIM3 + - - 0 0 
6 MM1* +  KMS-12-BM + 1 4 
7 JIM3 + L363 + 2 3 
8 KMS-11 + MM1* -†‡ 4 0 
9 MM1* +  - - 0 0 
10 RPMI-8226 + KMS-11 +  3 2 
11 RPMI-8226 + JJN-3 +  2 2 
12 LP-1 + MM1* + 5 1 
In
te
rn
al
 
(M
RC
 
Ho
lla
n
d) 
13 AMO-1 + RPMI-8226 + 40 38 
14 AMO-1 + SK-MM-2 + 20 22 
15 ARH-77 + KMS-12-BM + 10 8 
16 ARH-77 + OPM-2 + 50 51 
17 COLO-677 + LP-1 + ‡ 2.5 – 
18 COLO-677 + NCI-H929 + 30 36 
19 EJM + MOLP-8 + ‡ 5 – 
20 IM-9 + LP-1 + 40 45 
21 JJN-3 + MOLP-2 + 2.5 2 
22 KMS-12-PE + LOPRA-1 + 30 25 
23 L-363 + JJN-3 + 5 3 
24 LOPRA-1 + KMS-12-PE + 10 9 
25 MOLP-8 + SK-MM-2 + 20 21 
26 MOLP-8 + EJM + 5 10 
27 NCI-H929  + IM-9 + 30 28 
28 OPM-2 + IM-9 + 5 4 
29 RPMI-8226  + U-266 +‡ 1 - 
30 U-266 + L-363 + 50 48 
31 AMO-1 + - - 0 0 
32 AMO-1 + NCI-H929 + 2 5 
33 EJM + MOLP-8 +‡ 5 3 
34 IM-9 + ARH-77 + 5 12 
35 IM-9 + ARH-77 + 1 5 
36 IM-9 + NCI-H929 + 1 2 
37 LOPRA-1 + JJN-3 - 1 0 
38 LOPRA-1 + KMS-12-BM - 1 0 
39 OPM-2 + MOLP-8 - 1 0 
40 OPM-2 + EJM + 1 2 
41 SKMM2 + JJN-3 + 5 4 
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*Either MM1.R or MM1.S cell line; both are derived from the same origin, and have identical 
SNP profiles  
†Only two informative SNPs present to allow identification of contaminating cell line 
‡A contamination was detected, but the contaminating cell line was misidentified or 
technically not feasible to identify 
 
Supplemental Figure Legends 
 
Supplemental Figure S1. Clustering of cell lines based on CNA profiling, including cell 
lines mis-identified as MM. The dendrogram on the left shows clusters generated using k-
means based on copy number ratios, where ratio 1 corresponds to baseline, lower ratios 
indicating a relative loss and higher numbers a relative gain. Below chromosomes are 
indicated by black and white blocks corresponding to odd and even chromosomes 
respectively. The X chromosome appears as grey. Cell type and gender of cell line donor 
are indicated by the colored row annotations on the right of the heatmap. Cell type legend: 
MM: Multiple myeloma; MM-EBV: Multiple myeloma, EBV transformed; MM-mix: Cell line 
identified as cross-contaminated RPMI-8226; PLAS: Plasmacytoma; PCL: Plasma cell 
leukemia.  
 
Supplemental Figure S2. Detail of focal CNA drift of multiple myeloma cell lines with 
increasing passages. Copy number ratio profiles of digitalMLPA probes including identifiers 
of genes assayed directly by digitalMLPA; A. on chr17 in MM1.R cell line, and B. on chr7 in 
RPMI-8226 cell line.  
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